AI biotech Turbine raises $25M Series B to sell 'Virtual Lab' to pharma

Budapest-based Turbine has closed a $25 million Series B round, funding the next iteration of the decade-old startup’s long-running quest to build virtual cells. While interest in virtual cells — AI models that simulate cell behavior ...